Yinghua Shao

Title: **Yinghua Shao: Innovator in Pharmaceutical Crystals**

Introduction

Yinghua Shao is an esteemed inventor based in Zhejiang, China, known for his groundbreaking contributions to the field of pharmaceutical science. With a focus on innovative methods for drug formulation, he has made significant strides in enhancing the stability and solubility of pharmaceutical compounds.

Latest Patents

Yinghua Shao holds a patent for a unique crystalline form of fenofibrate, identified as Form IV. This invention specifically outlines the preparation methods for Form IV, which are characterized by simplicity and ease of operation. The X-ray powder diffraction pattern reveals distinct characteristic peaks at 14.15±0.2°, 15.94±0.2°, 16.49±0.2°, 17.45±0.2°, 20.21±0.2°, and 22.87±0.2°. Notably, the manufacturing process employs water as a medium along with pharmaceutically accepted excipients, ensuring non-toxicity and minimal environmental impact. Stability tests indicate that Form IV remains stable under varying conditions and offers enhanced solubility compared to previous crystal forms.

Career Highlights

Yinghua Shao is associated with Hangzhou Solipharma Co., Ltd., where he has actively contributed to research and development in pharmaceutical formulations. His commitment to creating innovative products has established him as a valuable asset within the organization.

Collaborations

In his professional journey, Yinghua has collaborated with notable colleagues, including Xiangjun Shi and Xiaohong Sheng. Their teamwork has fostered an environment conducive to creative solutions and advanced research in the pharmaceutical sector.

Conclusion

Yinghua Shao exemplifies the spirit of innovation in the pharmaceutical industry through his inventive approach to drug formulations. His patented methods for preparing Form IV of fenofibrate not only improve solubility but also adhere to environmentally friendly practices, showcasing his dedication to both scientific advancement and sustainability.